Author： King J.R.
Publisher： Adis International
ISSN： 0312-5963
Source： Clinical Pharmacokinetics, Vol.43, Iss.5, 2004-01, pp. : 291-310
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
The Role of Protease Inhibitor Therapy in Children with HIV Infection
Pediatric Drugs, Vol. 4, Iss. 9, 2002-01 ,pp. :
Dual protease inhibitor therapy in the management of the HIV-1
Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 7, 2000-12 ,pp. :
Metabolic Complications Associated with HIV Protease Inhibitor Therapy
By Nolan D.
Drugs, Vol. 63, Iss. 23, 2003-01 ,pp. :
Dual-protease inhibitor (PI) therapy was associated with an increased rate of virological failure
Inpharma, Vol. 1, Iss. 1625, 2008-01 ,pp. :